Hydrophilic polymer embolization is a rare complication after endovascular procedures that is currently underappreciated. Present understanding on this phenomenon relies on sparse case reports with histologic evidence of foreign polymers in end-organ tissue. Here, we report two deaths associated with hydrophilic polymer embolization after complex thoracic endovascular aortic repair. (J Vasc Surg Cases and Innovative Techniques 2019;5:423-6.) 
Rapid advancements of endovascular devices in the last decade have paved the way for novel interventions for vascular diseases. The development of hydrophilic coatings has further improved the handling of endovascular devices, thereby allowing smoother and more precise targeting of treatment areas. However, in the past few years, there have been increasing case reports of hydrophilic polymer embolization (HPE) that have resulted in a range of clinical sequelae from asymptomatic to death. Here we report our experience with two fatal cases of HPE after thoracic endovascular aortic repair (TEVAR). Both patients' families consented to the publication of these cases. Postoperatively, she developed an acute kidney injury as well as aspiration pneumonia. She was extubated on postoperative day (POD) 7 but suffered a bradycardiac arrest on POD 8, requiring reintubation. After arrest, she was found to have a subacute stroke, probably secondary to an embolic shower to the left frontal and occipital cortex (Fig 1) , leaving her with partial right hemiparesis. On POD 14, she went into shock and fulminant hepatic failure. Computed tomography (CT) demonstrated a grossly ischemic liver and an ischemic left kidney (Fig 1) . She became densely paraplegic on POD 15. The patient was transitioned to comfort care and died on POD 17.
CASE REPORTS
Autopsy determined the cause of death to be systemic shock and multiorgan failure. Microscopic hydrophilic polymer emboli within multiple organs likely contributed to tissue infarction. Scattered nonorganic microemboli in the liver, kidneys, brain, lungs, spleen, bowel, and lower extremity soft tissue were found (Fig 2) . However, all visceral bypass grafts were patent. The pathology report described the appearance of the hydrophilic polymer embolic material as similar to that in previous reports. (Fig 3) . Her condition continued to worsen and was made comfort care on POD 5.
Autopsy examination confirmed hydrophilic polymer microemboli scattered throughout the brain. Fragments of polymer coating were identified in the right kidney with associated infarction and glomerulosclerosis of nearly half the parenchyma (Fig 3) . Given her already compromised renal function, this was thought to have contributed to her failing health; however, compared with her neurologic symptoms and findings, her renal failure was unlikely to be the cause of death. Last, emboli
were also discovered embedded in the aortic adventitia and liver (Fig 3) .
DISCUSSION
Hydrophilic coatings provide a smooth interphase during procedures. However, it is well known that the polymer coating can be dislodged by mechanical forces during typical use. Despite this, the rate of reported serious adverse events is exceedingly low. A review by Mehta and Mehta 2 revealed nine deaths from HPE since 2010 with 11 device recalls. In almost all cases, the emboli are found on postmortem autopsy, suggesting that the rate of subclinical and nonfatal embolization is likely to be much higher. Chopra et al 1 reviewed retrospective studies from autopsies, 3 coronary stenting procedures, 4 and endovascular aortic repairs, 5 revealing incidence rates ranging from 4% to 45%. It is unclear whether the amount or size of HPE is associated with the clinical outcome. Conceivably, a larger hydrophilic device kept inside the patient for a longer time is likely to generate a greater amount of HPE. This was demonstrated by Stanley et al 6 in swine models.
Consequently, complex TEVAR cases requiring large hydrophilic sheaths inside the patient for long periods may result in significant amounts of polymer dislodgment and are more likely to have detrimental clinical sequelae as seen in the two cases presented here. Overall, HPE is an underappreciated complication after endovascular interventions. Whereas the reported clinical sequelae appear to be rare and often are found only on autopsy, partial or total organ injury could have previously been attributed to other causes. Physicians should become more aware of this phenomenon and include it in their differentials of unexplained organ failure after complex endovascular procedures. Better understanding of its incidence will rely on diligent reporting by physicians of this rare complication. Future studies should also focus on the differences in the rate 
